Question Period Notes
About this information
In accordance with the Access to Information Act, the government proactively publishes the package of question period notes that were prepared by a government institution for the minister and that were in use on the last sitting day in June and December.
The question period notes may be partially or fully redacted in accordance with the legislation; for example, if the notes contain information related to national security or personal information. (Learn more about exemptions and exclusions.)
If you find a question period note of interest, you may make an access to information request in order to obtain it.
N/A
N/A
Safety is a central consideration for any health product, including vaccines. Canada’s rigorous regulatory system assesses vaccines for safety, efficacy and quality before they are authorized. However, no health product is completely risk-free.
Post-market vaccine surveillance is required to monitor and understand how vaccines behave in the entire population and their real-world impact. Vaccine safety surveillance is critical for rapidly detecting and responding to safety issues, ensuring that the benefits of the vaccine continue to outweigh the risks and supporting vaccine uptake by building public confidence in Canada’s immunization programs.
Antimicrobial resistant infections are becoming more frequent and increasingly difficult to treat. Coordinated ‘One Health’ action across the human and animal health sectors and the environment is needed to address the growing threat to Canadians and our healthcare system.
The Government of Canada is committed to improving the health and well-being of autistic Canadians and to supporting caregivers. The Government is also committed to working collaboratively with provinces, territories, families, autistic Canadians, and stakeholders toward the creation of a national autism strategy.
People affected by the floods and resulting disruptions to supply chains and the availability of essential goods have been travelling to or through the United States to secure the necessities of life (food, fuel) or to transit through the U.S. to return to their communities. On November 21, 2021, the Government of Canada announced an exemption from the requirement for these travellers to obtain a PCR test upon return to Canada, along with the application of some other border measures. These exemptions do not apply to non-essential, discretionary travel.
Following the announcement, some travellers have been fined for non-compliance with the PCR requirement and have been instructed to quarantine.
The Public Health Agency of Canada (PHAC) has put successive border measures in place, in response to COVID-19, under the Quarantine Act.
Since the beginning of the COVID-19 pandemic, Canada has engaged with international partners bilaterally and multilaterally, through the G7, the G20, the World Health Organization (WHO), and the Pan American Health Organization to help inform our domestic response and to contribute to global efforts on fighting COVID-19.
Omicron (B.1.1.529), the newly designated COVID-19 variant of concern, has been detected in Canada.
Dementia is a set of symptoms affecting brain function. It is often characterized by changes in memory, mood, judgement and other cognitive functions. Alzheimer’s disease is the most common form. In 2017–2018, almost 452,000 Canadians aged 65 and older were living with diagnosed dementia. This number is expected to increase with Canada’s growing and aging population.